Introduction.- Section I Pharma.- Historical Perspectives.- Risk, Control and Compliance..- Sterility and Beyond.- LVPs and SMDs.- Specification Determination.- Static and Dynamic Models (Biodiversity and Heterogeneity) .- Test Development and Validation.- Diminishing Analytics.- Control in Biologics Manufacture.- Depyrogenation and Medical Devices.- Nanoparticles / Problematic Drug Types.- New Frontiers.- Section II Limulus.- Evolution, a Living Fossil and Other Model Arthropods.- Water, Water Everywhere.- Survival and Mass Extinction Events.- Limulus Soup / Hemolymph.- Is Innate Modeling Enough?.- A Foreboding.- Section III Mammalian.- Innate is Inborn.- The Host Response: Fever and Inflammation.- . Parallel Immune Systems: Architecture and Mechanisms.- Structural Change is Functional Change (Hand in Glove).- Endotoxin and Adjuvanticity in Vaccinology.- Advances in Diagnostics.- The Big S.

Kevin Williams graduated from Texas A&M in 1982 with a BS in Microbiology.  From there spent 30 years at Eli Lilly in Indianapolis.  After retirement he has been at Hospira, Lonza, GE, and now BioMerieux .